EHMT2 and breast cancer: Consistent with this, our findings show that G9a inhibition has a more profound inhibitory effect on cancer growth in basal-like TNBC > claudin-low TNBC > luminal A BC, highlighting G9a’s broader influence across different BC subtypes via distinct pathways and mechanisms.